Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A Phase I/II, Open Label, Multi-centre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of the Tor Kinase Inhibitor AZD8055 Administered Orally to Patients with Advanced Solid Tumours, Lymphomas and Endometrial Carcinoma https://kusajili.com:443/Trial/Kb3k-ujLlkOGtC92kU_V3Q%24a-phase-iii-open-label-multi-centre-study-to-assess-the-safety-tolerability-pharmacokinetics-and-preliminary-efficacy-of-the-to
I have read and accept the terms of use of the site and the Privacy Policy
Send your message